Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
These medications can lead to significant weight loss and offer additional benefits such as improved blood sugar control and reduced cardiovascular risk factors
The SURMOUNT-1 trial recorded 22.5% average weight loss at this dose, roughly 52 pounds
Clinical trials show that Tesamorelin continues producing visceral fat loss through at least week 52, even when overall weight stabilizes
Fukunaka A, Fujitani Y
Two core findings seem to have driven this: Inadequate smoke studies
US$ 24.39
US$ 29.74
US$ 23.43
US$ 26.09
US$ 21.79
US$ 21.53
US$ 25.38
US$ 20.12
US$ 26.54
US$ 23.77
US$ 25.68
